Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Moonlake Immunotherapeutics (MLTX) since 2020 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Moonlake Immunotherapeutics. Table 2 shows the detailed insider transactions. This company's CIK number is 1821586.
Total stock buying since 2020: $138,232,693.
Total stock sales since 2020: $138,078,600.
Total stock option exercises since 2020: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 23,500 | $1,146,565 | 23,500 | $0 |
| 2024 | 0 | $0 | 2,555,740 | $131,014,669 | 0 | $0 |
| 2023 | 2,429,151 | $101,132,693 | 100,000 | $5,917,366 | 0 | $0 |
| 2022 | 2,850,000 | $28,500,000 | 0 | $0 | 0 | $0 |
| 2020 | 860,000 | $8,600,000 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-07 | 0 | $0 | 23,500 | $1,146,565 | 23,500 | $0 |
| 2024-10 | 0 | $0 | 2,171,000 | $109,190,120 | 0 | $0 |
| 2024-02 | 0 | $0 | 384,740 | $21,824,549 | 0 | $0 |
| 2023-12 | 0 | $0 | 100,000 | $5,917,366 | 0 | $0 |
| 2023-10 | 352,051 | $20,324,634 | 0 | $0 | 0 | $0 |
| 2023-06 | 1,250,000 | $63,690,250 | 0 | $0 | 0 | $0 |
| 2023-03 | 827,100 | $17,117,809 | 0 | $0 | 0 | $0 |
| 2022-04 | 2,850,000 | $28,500,000 | 0 | $0 | 0 | $0 |
| 2020-10 | 860,000 | $8,600,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-07-03 | Moukheibir Catherine | Sale | 23,500 | 48.79 | 1,146,565 |
| 2025-07-03 | Moukheibir Catherine | Option Ex | 23,500 | .00 | 0 |
| 2024-10-04 | Sturge Simon | Sale | 171,000 | 53.72 | 9,186,120 |
| 2024-10-04 | Lampert Mark N | Sale | 2,000,000 | 50.00 | 100,004,000 |
| 2024-02-29 | Santos Da Silva Jorge (Chief Executive Officer) | Sale | 4,740 | 55.89 | 264,918 |
| 2024-02-28 | Reich Kristian (Chief Scientific Officer) | Sale | 60,000 | 55.00 | 3,300,000 |
| 2024-02-28 | Santos Da Silva Jorge (Chief Executive Officer) | Sale | 56,065 | 55.00 | 3,083,575 |
| 2024-02-27 | Reich Kristian (Chief Scientific Officer) | Sale | 58,922 | 55.00 | 3,240,710 |
| 2024-02-27 | Santos Da Silva Jorge (Chief Executive Officer) | Sale | 62,810 | 55.00 | 3,454,550 |
| 2024-02-21 | Reich Kristian (Chief Scientific Officer) | Sale | 1,078 | 55.30 | 59,618 |
| 2024-02-21 | Santos Da Silva Jorge (Chief Executive Officer) | Sale | 1,125 | 55.27 | 62,178 |
| 2024-02-20 | Reich Kristian (Chief Scientific Officer) | Sale | 20,000 | 57.44 | 1,148,800 |
| 2024-02-20 | Santos Da Silva Jorge (Chief Executive Officer) | Sale | 20,000 | 57.44 | 1,148,800 |
| 2024-02-16 | Reich Kristian (Chief Scientific Officer) | Sale | 20,000 | 60.15 | 1,203,000 |
| 2024-02-16 | Santos Da Silva Jorge (Chief Executive Officer) | Sale | 20,000 | 60.15 | 1,203,000 |
| 2024-02-15 | Reich Kristian (Chief Scientific Officer) | Sale | 20,000 | 60.16 | 1,203,300 |
| 2024-02-15 | Santos Da Silva Jorge (Chief Executive Officer) | Sale | 20,000 | 60.18 | 1,203,600 |
| 2024-02-14 | Reich Kristian (Chief Scientific Officer) | Sale | 20,000 | 62.42 | 1,248,500 |
| 2023-12-20 | Bodenstedt Matthias (Chief Financial Officer) | Sale | 5,264 | 58.34 | 307,101 |
| 2023-12-19 | Bodenstedt Matthias (Chief Financial Officer) | Sale | 94,736 | 59.22 | 5,610,265 |
| 2023-10-05 | Cormorant Private Healthcare Fund Iv Lp | Buy | 58,839 | 59.90 | 3,524,279 |
| 2023-10-04 | Cormorant Private Healthcare Fund Iv Lp | Buy | 67,814 | 57.32 | 3,887,030 |
| 2023-10-03 | Cormorant Private Healthcare Fund Iv Lp | Buy | 150,487 | 57.25 | 8,615,681 |
| 2023-10-02 | Cormorant Private Healthcare Fund Iv Lp | Buy | 74,911 | 57.37 | 4,297,644 |
| 2023-06-30 | Chen Bihua | Buy | 800,000 | 50.00 | 40,000,000 |
| 2023-06-26 | Chen Bihua | Buy | 450,000 | 52.65 | 23,690,250 |
| 2023-03-21 | Chen Bihua | Buy | 238,511 | 21.70 | 5,175,927 |
| 2023-03-20 | Chen Bihua | Buy | 588,589 | 20.29 | 11,941,882 |
| 2022-04-05 | Chen Bihua | Buy | 2,850,000 | 10.00 | 28,500,000 |
| 2020-10-22 | Helix Holdings Llc | Buy | 430,000 | 10.00 | 4,300,000 |
| 2020-10-22 | Chen Bihua (CEO and Chairman) | Buy | 430,000 | 10.00 | 4,300,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of MLTX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Moonlake Immunotherapeutics (symbol MLTX, CIK number 1821586) see the Securities and Exchange Commission (SEC) website.